Pathios Therapeutics

Pathios Therapeutics is an early-stage drug discovery company dedicated to developing therapies for autoimmune diseases and cancer. Pathios Therapeutics is currently engaged in a comprehensive drug discovery program aimed at identifying novel small-molecule modulators of GPR65, which are expected to have utility in a range of autoimmune diseases as well as certain cancers. Pathios Therapeutics also has a broad interest in acid-sensing receptors within the immune system and their potential applications, with these receptors offering therapeutic benefits across various diseases.